Contact a Trial Coordinator for more information on our trials
This is an open label, multi-center, Phase 1/2 clinical trial in subjects with recurrent
For more information on enrollment into the current VAL-083 trial, please contact us or visit clinicaltrials.gov for location information.
The safety and efficacy of the investigational use of this product has not been determined. There is no guarantee that the investigational use listed will be filed with and/or approved for marketing by a regulatory agency.